An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis

NCT06613490 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Antisynthetase Syndrome
Rheumatoid Arthritis

Interventions

BIOLOGICAL: anti CD19 CAR NK cells

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]